Atara biotherapeutics to present at the 39th annual j.p. morgan healthcare conference

South san francisco, calif.--(business wire)--atara biotherapeutics, inc. (nasdaq: atra), a pioneer in t-cell immunotherapy, leveraging its novel allogeneic ebv t- cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced that pascal touchon, president and chief executive officer, will present at the 39th annual j.p. morgan healthcare conference on wednesday, january 13 at 1:30 pm pst
ATRA Ratings Summary
ATRA Quant Ranking